D
Daniel Felsky
Researcher at Centre for Addiction and Mental Health
Publications - 91
Citations - 2404
Daniel Felsky is an academic researcher from Centre for Addiction and Mental Health. The author has contributed to research in topics: Medicine & Biology. The author has an hindex of 20, co-authored 57 publications receiving 1698 citations. Previous affiliations of Daniel Felsky include University of Toronto & Broad Institute.
Papers
More filters
Journal ArticleDOI
A multi-omic atlas of the human frontal cortex for aging and Alzheimer’s disease research
Phillip L De Jager,Phillip L De Jager,Yiyi Ma,Cristin McCabe,Jishu Xu,Badri N. Vardarajan,Daniel Felsky,Daniel Felsky,Hans-Ulrich Klein,Hans-Ulrich Klein,Charles C. White,Mette A. Peters,Ben Lodgson,Parham Nejad,Anna Tang,Lara M. Mangravite,Lei Yu,Chris Gaiteri,Sara Mostafavi,Julie A. Schneider,David A. Bennett +20 more
TL;DR: The systematic profiling of the dorsolateral prefrontal cortex obtained from a subset of autopsied individuals enrolled in the Religious Orders Study or the Rush Memory and Aging Project, which are jointly designed prospective studies of aging and dementia with detailed, longitudinal cognitive phenotyping during life and a quantitative, structured neuropathologic examination after death, is initiated.
Journal ArticleDOI
Large eQTL meta-analysis reveals differing patterns between cerebral cortical and cerebellar brain regions.
Solveig K. Sieberts,Thanneer M. Perumal,Minerva M. Carrasquillo,Mariet Allen,Joseph S. Reddy,Gabriel E. Hoffman,Kristen K. Dang,John N. Calley,Phillip J. Ebert,James A. Eddy,Xue Wang,Anna K. Greenwood,Sara Mostafavi,Sara Mostafavi,S Akbarian,J Bendl,M S Breen,K Brennand,L Brown,A Browne,J D Buxbaum,A Charney,Andrew Chess,Couto L,Gregory E. Crawford,Devillers O,Bernie Devlin,Amanda Dobbyn,E Domenici,M Filosi,E Flatow,Nancy Francoeur,John F. Fullard,S E Gil,Kiran Girdhar,A Gulyás-Kovács,R.E. Gur,C G Hahn,Vahram Haroutunian,Mads E. Hauberg,Laura M. Huckins,Rivka Jacobov,Y Jiang,Jessica S. Johnson,Bibi Kassim,Y Kim,Lambertus Klei,Robin Kramer,Mario Lauria,Thomas Lehner,David A. Lewis,Barbara K. Lipska,Kelsey S. Montgomery,R Park,C Rosenbluh,Panagiotis Roussos,Douglas M. Ruderfer,G Senthil,Hardik Shah,Laura G. Sloofman,L Song,E Stahl,P.F. Sullivan,R Visintainer,J Wang,Y C Wang,Jennifer Wiseman,E Xia,W Zhang,Elizabeth Zharovsky,L Addis,S N Addo,David C. Airey,Matthias Arnold,David A. Bennett,Y Bi,K Biber,Colette Blach,E Bradhsaw,Paul Brennan,R Canet-Aviles,S Cao,A Cavalla,Yooree Chae,W W Chen,J Cheng,David A. Collier,J L Dage,Eric B. Dammer,J W Davis,John B. Davis,Derek Drake,D Duong,Brian J. Eastwood,Michelle E. Ehrlich,B Ellingson,B W Engelmann,S Esmaeelinieh,Daniel Felsky,Cory C. Funk,Chris Gaiteri +100 more
TL;DR: A colocalization analysis is applied to identify genes underlying the GWAS association peaks for schizophrenia and identify a potentially novel gene colocalized with lncRNA RP11-677M14.
Journal ArticleDOI
Neuroimaging Evidence for the Deficit Subtype of Schizophrenia
Aristotle N. Voineskos,George Foussias,Jason P. Lerch,Daniel Felsky,Gary Remington,Tarek K. Rajji,Nancy J. Lobaugh,Bruce G. Pollock,Benoit H. Mulsant +8 more
TL;DR: White matter tract disruption as a neurobiological feature of the deficit syndrome and reductions in cortical thickness as a common feature of patients with a diagnosis of schizophrenia are demonstrated.
Journal ArticleDOI
The brain-derived neurotrophic factor Val66Met polymorphism and prediction of neural risk for Alzheimer disease.
Aristotle N. Voineskos,Jason P. Lerch,Daniel Felsky,Sajid A. Shaikh,Tarek K. Rajji,Dielle Miranda,Nancy J. Lobaugh,Benoit H. Mulsant,Bruce G. Pollock,James L. Kennedy +9 more
TL;DR: The novel findings provide convergent evidence in vivo for a BDNF genetic mechanism of susceptibility in an intermediate phenotype related to AD by examining cortical thickness, fractional anisotropy of white matter tracts, and episodic memory performance.
Journal ArticleDOI
The genome-wide supported microRNA-137 variant predicts phenotypic heterogeneity within schizophrenia
Tristram A. Lett,M. Mallar Chakravarty,M. Mallar Chakravarty,Daniel Felsky,Daniel Felsky,Eva J. Brandl,Arun K. Tiwari,Vanessa F. Gonçalves,Vanessa F. Gonçalves,Tarek K. Rajji,Tarek K. Rajji,Zafiris J. Daskalakis,Zafiris J. Daskalakis,Herbert Y. Meltzer,J A Lieberman,Jason P. Lerch,Benoit H. Mulsant,Benoit H. Mulsant,James L. Kennedy,James L. Kennedy,Aristotle N. Voineskos,Aristotle N. Voineskos +21 more
TL;DR: The findings suggest that MIR137 substantially influences variation in phenotypes that are thought to have an important role in clinical outcome and treatment response and the possible consequences of genetic risk factors may be distinct in patients with schizophrenia compared with healthy controls.